Michael Ropacki is the founder of Oryzon Genomics. Oryzon Genomics has raised $61M in total funding. Latest round: Growth.
Michael Ropacki is the Chief Medical Officer for CNS at Oryzon Genomics. He is scheduled to present the final results from the company's Phase IIb PORTICO trial at the 37th European College of Neuropsychopharmacology (ECNP) annual congress on September 23.
Full founder directory · Investor directory · Company funding database · Fundraising library